NeoStem Inc., of New York, appointed Martyn D. Greenacre and Andrew L. Pecora to the board...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

NeoStem Inc., of New York, appointed Martyn D. Greenacre and Andrew L. Pecora to the board...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

InteRNA Technologies BV, of Utrecht, the Netherlands, appointed Mark Vaeck and Sanne Weijzen to its board chaired by Anker Lundemose...It also named Robert B. Shapiro and Jeffrey B. Kindler to its board

Emerald BioStructures Inc., of Bainbridge Island, Wash., appointed Johan Pontin chairman and CEO...Fate Therapeutics Inc., of San Diego, appointed William H. Rastetter chairman and interim CEO...Forma Therapeutics Inc., of Watertown, Mass., named Jaime Escobedo vice president of biology and Mark J. Tebbe vice president of medicinal and computational chemistry and appointed Dennis France executive director and head of biomolecular screening

Codexis Inc., of Redwood City, Calif., named Wesley J. Bolsen vice president and chief marketing officer...Curis Inc., of Lexington, Mass., appointed Maurizio Voi chief medical and chief development officer

Lycera Corp., of Ann Arbor, Mich., named Kathleen M. Metters president and CEO...Medivir AB, of Huddinge, Sweden, appointed Maris Hartmanis president and CEO...PDL BioPharma Inc., of Incline Village, Nev., retained Franklin M. Berger and Evan Bedil as advisors to assist with the identification and evaluation of royalty-bearing asset acquisition opportunities

It also named Gerald Commissiong president and CEO and appointed Owen Garrick strategic advisor to its board...Anaptys Bio Inc., of San Diego, named Carol G. Gallagher executive chair and promoted Hamza Suria to chief business officer and acting CEO

Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Kenneth J. Zuerblis executive vice president and chief financial officer...Silence Therapeutics plc, of London, appointed Thomas Christely CEO and named Tony Sedgwick chief business officer...Sucampo Pharmaceuticals Inc., of Bethesda, Md., added Greg Deener as vice president of marketing, strategy and implementation

and Alan W. Dunton as consulting chief medical officer...Medivir AB, of Huddinge, Sweden, made several recent appointments, including Maris Hartmanis as deputy CEO and chief operating officer...and Jens D. Kristensen as executive vice president of clinical

Affimed Therapeutics AG, of Heidelberg, Germany, named Adi Hoess CEO and appointed Rolf Guenther chief operating officer...and Alexander H. Burgess as vice president of marketing...CardioDx, of Palo Alto, Calif., named Andrew L. Guggenhime chief financial officer and appointed Mark Monane chief medical officer

Tim Henkel as executive vice president and head of R&D...Doug Gessl as chief operating officer and chief financial officer...and Lisa Wittmer as vice president of regulatory affairs

PharmacoFore Inc., of San Carlos, Calif., appointed Joseph Stauffer chief medical officer and vice president of corporate strategy and named Narinder Banait vice president of intellectual property...ProtAffin AG, of Graz, Austria, appointed Frank Walsh chairman and named Tim Edwards to the board

GenVec Inc., of Gaithersburg, Md., elected Adel A. F. Mahmoud and Edward M. Connor Jr...It also named Timothy D. Kasbe senior vice president and chief information officer...Medicure Inc., of Winnipeg, Manitoba, appointed Dawson Reimer president and chief operating officer

Ascletis Inc., of Research Triangle Park, N.C., and Hangzhou, China, appointed Allan Baxter chief strategy officer...Genesis Biopharma Inc., of Los Angeles, added David Voyticky and Merrill A. McPeak to its board and named Laszlo Radvanyi to its scientific and medical advisory board

The people who are assigned to the committee include Michael Conte, William Marston, Richard Powell and Michael Smith...Ablexis LLC, of San Francisco, appointed Jake Bauer senior director of corporate development and business operations...Agennix AG, of Planegg, Germany, appointed Jill Porter senior vice president of pharmaceutical development and appointed Christine Boisclair senior vice president of global regulatory affairs

Vivo Ventures LLC, of Palo Alto, Calif., promoted Chen Yu and James Zhao to managing partners...Xceleron Ltd., of York, UK, appointed David Roblin to its board and named Stuart Best senior director of operations...XOMA Ltd., of Berkeley, Calif., appointed Paul Rubin vice president and chief medical officer

Spectrum Pharmaceuticals Inc., of Henderson, Nev., promoted Steven M. Fruchtman to vice president and chief medical officer and Nozar Azarnia to vice president of biostatistics and data management...Tetragenetics Inc., of Cambridge, Mass., appointed Marco Cacciuttolo president and CEO...It also named Ben Machielse and Robert Gailus to its board

Pacira Pharmaceuticals Inc., of Parsippany, N.J., appointed Laura A. Brege and Paul J. Hastings to its board...PolyTherics Ltd., of London, named John Burt CEO and board member after Keith Powell stepped down...Resolve Therapeutics LLC, of Seattle, named Peter Kiener chairman and added Somu Subramaniam as an observer to the board

It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board